A detailed history of Foresight Capital Management Advisors, Inc. transactions in Novartis Ag stock. As of the latest transaction made, Foresight Capital Management Advisors, Inc. holds 22,875 shares of NVS stock, worth $2.37 Million. This represents 1.59% of its overall portfolio holdings.

Number of Shares
22,875
Previous 21,247 7.66%
Holding current value
$2.37 Million
Previous $2.26 Million 16.36%
% of portfolio
1.59%
Previous 1.56%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

BUY
$106.13 - $120.89 $172,779 - $196,808
1,628 Added 7.66%
22,875 $2.63 Million
Q2 2024

Jul 10, 2024

BUY
$92.57 - $107.37 $119,693 - $138,829
1,293 Added 6.48%
21,247 $2.26 Million
Q1 2024

Apr 16, 2024

BUY
$95.27 - $108.47 $106,797 - $121,594
1,121 Added 5.95%
19,954 $1.93 Million
Q4 2023

Jan 10, 2024

BUY
$92.27 - $101.54 $1.74 Million - $1.91 Million
18,833 New
18,833 $1.9 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $223B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Foresight Capital Management Advisors, Inc. Portfolio

Follow Foresight Capital Management Advisors, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Foresight Capital Management Advisors, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Foresight Capital Management Advisors, Inc. with notifications on news.